{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:30:20Z","timestamp":1776882620322,"version":"3.51.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Psoriasis is a common chronic inflammatory skin disease characterized by an external red rash that is caused by abnormal proliferation and differentiation of keratinocytes and immune T cells. This study aimed to elucidate the role of aminooxy acetic acid (AOA) in alleviating psoriasis from the perspective of immunology and metabolomics. Therefore, contributing to the development of new drugs as candidates for psoriasis treatment.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To investigate the symptom-alleviating effects and the related mechanisms of AOA on the treatment of psoriasis, we used a 12-O-tetradecanoylphorbol-13-acetate-induced psoriasis-like skin mouse model and interleukin (IL)-17-stimulated human keratinocytes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The results showed that AOA ameliorated psoriasis-related symptoms and decreased inflammation-associated antimicrobial peptides and T-helper 17 (Th17)-associated cytokines in a mouse model of psoriasis. Furthermore, AOA inhibited the activation of mechanistic target of rapamycin (mTOR) by suppressing serine metabolism-related genes. Importantly, mTOR inhibition ameliorated psoriatic disease by affecting the differentiation of various T cells and normalizing the Th17\/regulatory T (Treg) cell balance. In addition, IL-17-stimulated human keratinocytes showed the same results as in the <jats:italic>in vivo<\/jats:italic> experiments.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Taken together, these results suggest that targeting the serine metabolism pathway in the treatment of psoriasis is a novel strategy, and that AOA could be utilized as a novel biologic to treat psoriasis.<\/jats:p>","DOI":"10.3389\/fphar.2023.1215861","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:40:25Z","timestamp":1692186025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism"],"prefix":"10.3389","volume":"14","author":[{"given":"Jong Yeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Jung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eonho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"eabm7902","DOI":"10.1126\/sciadv.abm7902","article-title":"Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms","volume":"8","author":"Cappello","year":"2022","journal-title":"Sci. Adv."},{"key":"B2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.molmed.2020.04.004","article-title":"Metabolic pathways that control skin homeostasis and inflammation","volume":"26","author":"Cibrian","year":"2020","journal-title":"Trends Mol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40268-016-0152-x","article-title":"Efficacy of immunobiologic and small molecule inhibitor drugs for psoriasis: a systematic review and meta-analysis of randomized clinical trials","volume":"17","author":"De Carvalho","year":"2017","journal-title":"Drugs R. D."},{"key":"B4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17a, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis","volume":"21","author":"Furue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin. Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/jid.2011.486","article-title":"Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 \"alarmins\" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis","volume":"132","author":"Hegyi","year":"2012","journal-title":"J. Invest. Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"119655","DOI":"10.1016\/j.lfs.2021.119655","article-title":"Effect of Baricitinib on TPA-induced psoriasis like skin inflammation","volume":"279","author":"Hiraganahalli Bhaskarmurthy","year":"2021","journal-title":"Life Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"788940","DOI":"10.3389\/fimmu.2021.788940","article-title":"The role of helper T cells in psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"109615","DOI":"10.1016\/j.biopha.2019.109615","article-title":"Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models","volume":"121","author":"Jiang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1021\/pr500782g","article-title":"LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNF\u03b1 treatment","volume":"14","author":"Kamleh","year":"2015","journal-title":"J. Proteome Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.3390\/jcm10173880","article-title":"The defect in regulatory T cells in psoriasis and therapeutic approaches","volume":"10","author":"Kanda","year":"2021","journal-title":"J. Clin. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u03b2-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp. Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.immuni.2012.04.010","article-title":"The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury","volume":"37","author":"Lai","year":"2012","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-1212-4_1","article-title":"Isolation of T cells from the skin","volume":"1193","author":"Lorenz","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.cmet.2017.01.014","article-title":"Serine is an essential metabolite for effector T cell expansion","volume":"25","author":"Ma","year":"2017","journal-title":"Cell Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J. Invest. Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1365-2133.2000.04713.x","article-title":"Topical preparations for the treatment of psoriasis: a systematic review","volume":"146","author":"Mason","year":"2002","journal-title":"Br. J. Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/1566524020666200211112219","article-title":"Aminooxy-acetic acid inhibits experimental autoimmune uveitis by modulating the balance between effector and regulatory lymphocyte subsets","volume":"20","author":"Mei","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br. J. Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00403-017-1760-1","article-title":"The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease","volume":"309","author":"Ottas","year":"2017","journal-title":"Arch. Dermatol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000330330","article-title":"Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response","volume":"223","author":"Quaglino","year":"2011","journal-title":"Dermatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","article-title":"T cells involved in psoriasis vulgaris belong to the Th1 subset","volume":"102","author":"Schlaak","year":"1994","journal-title":"J. Invest. Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/s0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.05.001","article-title":"Malate-aspartate shuttle inhibitor aminooxyacetic acid leads to decreased intracellular ATP levels and altered cell cycle of C6 glioma cells by inhibiting glycolysis","volume":"378","author":"Wang","year":"2016","journal-title":"Cancer Lett."},{"key":"B33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-019-1411-x","article-title":"AMPK activation attenuates inflammatory pain through inhibiting NF-\u03baB activation and IL-1\u03b2 expression","volume":"16","author":"Xiang","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature23475","article-title":"Metabolic control of T(H)17 and induced T(reg) cell balance by an epigenetic mechanism","volume":"548","author":"Xu","year":"2017","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"109747","DOI":"10.1016\/j.biopha.2019.109747","article-title":"Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2\/STAT3 signal pathways","volume":"123","author":"Yuan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"104352","DOI":"10.1016\/j.phrs.2019.104352","article-title":"Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer","volume":"149","author":"Zeng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/eji.202048794","article-title":"Transcriptional and posttranslational regulation of Th17\/Treg balance in health and disease","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur. J. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1215861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:40:29Z","timestamp":1692186029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1215861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":37,"alternative-id":["10.3389\/fphar.2023.1215861"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1215861","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"1215861"}}